CA Patent

CA2509755A1 — Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Assigned to DiObex Inc · Expires 2004-07-22 · 22y expired

What this patent protects

Pharmaceutical compositions comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.

USPTO Abstract

Pharmaceutical compositions comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia.

Drugs covered by this patent

Patent Metadata

Patent number
CA2509755A1
Jurisdiction
CA
Classification
—
Expires
2004-07-22
Drug substance claim
No
Drug product claim
No
Assignee
DiObex Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.